UnknownNot Applicable

Impact of Mental Health and Cognitive Disorders on Quality of Life in Severe Covid-19 Survivors

65 participantsStarted 2023-06-01

Plain-language summary

The objective of this single-center retrospective observational study is to describe cognitive and psychological outcomes and their impact on quality of life after at least 3 months of intensive care unit (ICU) discharge in severe COVID-19 survivors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All 18 years and older patients with severe COVID-19, confirmed by real-time reverse transcriptase-polymerase chain reaction., admitted to a 15- bed intensive care unit of a tertiary hospital from April 2020 to October 2021. Exclusion Criteria: * Still hospitalized or inpatient in rehabilitation facility * Previous cognitive impairmant

What they're measuring

Montreal Cognitive Assessment Scale (MOCA)

Timeframe: 6 months after hospital discharge

Hospital Anxiety and depression scale (HADS)

Timeframe: 6 months after hospital discharge

Post-traumatic Stress Disorder Checklist: Civilian Version (PCL-C)

Timeframe: 6 months after hospital discharge

Trial details

NCT IDNCT05839327

SponsorHospital Sao Domingos

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-30

Contact for this trial

JOSE R AZEVEDO, MD, PhD

+559832168110 jrazevedo47@gmail.com

View on ClinicalTrials.gov More COVID-19 Post-Intensive Care Syndrome trials